Image

Clinical Efficacy of Platelet Transfusion

Clinical Efficacy of Platelet Transfusion

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

The aim of this study is to analyze the effect of the storage time of platelet concentrates on the occurrence of bleeding events during prophylactic platelet transfusions in patients with hematological malignancies.

Description

Since 2017, the preparation processes and shelf life of platelet concentrates (PCs) have been changed to increase transfusion safety and optimise transfusion processes. These changes have led to an increase in the total number of PCs transfused, a decrease in the number of platelets per PC and an increase in the number of platelets transfused per patient. Previous studies have shown that longer storage of platelets contributes to less in vivo recirculation of transfused platelets. Studies of haemostatic efficacy have generally not reported a significant effect. However, the haemostatic efficacy of PC stored for more or less than 5 days has not been evaluated. The ECLAT multicentre prognostic cohort study will prospectively and comparatively evaluate the haemorrhagic event in haematology patients with severe thrombocytopenia transfused according to the duration of PC storage.

Eligibility

Inclusion Criteria:

  • Patients with haematological malignancies or bone marrow aplasia with severe thrombocytopenia due to bone marrow failure related to the disease or treatments received
  • Severe thrombocytopenia requiring transfusion
  • Patient able to self-assess bleeding events
  • Non-opposition of the subject to participate in the study
  • Registered with the French social security system or benefiting from such a system.

Exclusion Criteria:

  • Acute promyelocytic leukaemia
  • Curative dosage of anticoagulants
  • Treatment with antiplatelet agents
  • Patient with proven thrombocytopenia of immunological origin, or disseminated intravascular coagulation
  • Patients with a clinically significant haemorrhagic event (WHO grade 2) in the 48 hours prior to transfusion
  • Indication for deplasmatised, cryopreserved and reduced-volume PCs
  • Patient refusing transfusion of labile blood products
  • Pregnant women or breast-feeding mothers
  • Adults subject to a legal protection measure or unable to express their consent
  • Persons deprived of their liberty by a judicial or administrative decision; persons under compulsory psychiatric care; persons admitted to a health or social care institution for purposes other than research
  • Subject in the exclusion period of another study

Study details
    Thrombocytopaenia
    Haematological Malignancies

NCT06805097

Centre Hospitalier Universitaire de Besancon

16 July 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.